In the closing of the recent trading day, Rivian Automotive (RIVN) stood at $15.28, denoting a -3% move from the preceding trading day.
Rivian Automotive plunged 27% in a month while R2 production appears on schedule. My base case remains that R2 demand will underwhelm and that Rivian will need additional capital. Despite downside risk, Rivian retains 'option value' tied to the R2 program and strong liquidity, limiting near-term downside.
Rivian Automotive (RIVN) concluded the recent trading session at $16.47, signifying a +1.92% move from its prior day's close.
Shares of Rivian Automotive Inc. (NASDAQ: RIVN) are trading for 14.2% less than a week ago.
Rivian (NASDAQ:RIVN) is approaching the most significant year of its brief public existence. The company has already overcome the toughest initial challenge for a new automaker: demonstrating its ability to design and manufacture high-quality vehicles.
Shares of Rivian Automotive (NASDAQ:RIVN) lost 10.76% over the past five trading sessions after losing 2.74% the five prior.
I am rating Rivian a cautious "buy," with a potential 50%+ upside from R2 exceeding investor expectations for growth, but investors may need to tolerate 20%+ short-term downside risk. Rivian's Software & Services segment grew 324% YoY, now 27% of revenue, aided by the Volkswagen partnership with growth expected to sustain with the Autonomy+ subscription. Production and deliveries slowed in 2025 as Rivian retooled for the mass-market R2 SUV, targeting a $45K price point and 155,000-unit capacity.
Rivian Automotive (RIVN) stock has dropped by 24.0% in under a month, falling from $22.45 on December 19, 2025, to $17.06 now. Is this dip a buying opportunity?
RIVN shares jump 31% in three months, but slowing deliveries, soft EV demand and heavy spending point to a bumpy road ahead.
Rivian Automotive (RIVN) closed the most recent trading day at $17.07, moving 2.46% from the previous trading session.
Rivian Automotive Inc (NASDAQ:RIVN) stock was last seen down 8.5% to trade at $17.24 after a downgrade from UBS to "sell" from "neutral" -- its second downgrade this week.
UBS analyst Joe Spak downgraded Rivian shares to Sell from Hold, according to FactSet. His price target went to $15 from $13 a share.